UniProt ID | EPHA1_HUMAN | |
---|---|---|
UniProt AC | P21709 | |
Protein Name | Ephrin type-A receptor 1 | |
Gene Name | EPHA1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 976 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein . |
|
Protein Description | Receptor tyrosine kinase which binds promiscuously membrane-bound ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Binds with a low affinity EFNA3 and EFNA4 and with a high affinity to EFNA1 which most probably constitutes its cognate/functional ligand. Upon activation by EFNA1 induces cell attachment to the extracellular matrix inhibiting cell spreading and motility through regulation of ILK and downstream RHOA and RAC. Plays also a role in angiogenesis and regulates cell proliferation. May play a role in apoptosis.. | |
Protein Sequence | MERRWPLGLGLVLLLCAPLPPGARAKEVTLMDTSKAQGELGWLLDPPKDGWSEQQQILNGTPLYMYQDCPMQGRRDTDHWLRSNWIYRGEEASRVHVELQFTVRDCKSFPGGAGPLGCKETFNLLYMESDQDVGIQLRRPLFQKVTTVAADQSFTIRDLVSGSVKLNVERCSLGRLTRRGLYLAFHNPGACVALVSVRVFYQRCPETLNGLAQFPDTLPGPAGLVEVAGTCLPHARASPRPSGAPRMHCSPDGEWLVPVGRCHCEPGYEEGGSGEACVACPSGSYRMDMDTPHCLTCPQQSTAESEGATICTCESGHYRAPGEGPQVACTGPPSAPRNLSFSASGTQLSLRWEPPADTGGRQDVRYSVRCSQCQGTAQDGGPCQPCGVGVHFSPGARGLTTPAVHVNGLEPYANYTFNVEAQNGVSGLGSSGHASTSVSISMGHAESLSGLSLRLVKKEPRQLELTWAGSRPRSPGANLTYELHVLNQDEERYQMVLEPRVLLTELQPDTTYIVRVRMLTPLGPGPFSPDHEFRTSPPVSRGLTGGEIVAVIFGLLLGAALLLGILVFRSRRAQRQRQQRQRDRATDVDREDKLWLKPYVDLQAYEDPAQGALDFTRELDPAWLMVDTVIGEGEFGEVYRGTLRLPSQDCKTVAIKTLKDTSPGGQWWNFLREATIMGQFSHPHILHLEGVVTKRKPIMIITEFMENGALDAFLREREDQLVPGQLVAMLQGIASGMNYLSNHNYVHRDLAARNILVNQNLCCKVSDFGLTRLLDDFDGTYETQGGKIPIRWTAPEAIAHRIFTTASDVWSFGIVMWEVLSFGDKPYGEMSNQEVMKSIEDGYRLPPPVDCPAPLYELMKNCWAYDRARRPHFQKLQAHLEQLLANPHSLRTIANFDPRMTLRLPSLSGSDGIPYRTVSEWLESIRMKRYILHFHSAGLDTMECVLELTAEDLTQMGITLPGHQKRILCSIQGFKD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | Phosphorylation | KEVTLMDTSKAQGEL CEEEEEECCCCCCCC | 20.40 | 16964243 | |
34 | Phosphorylation | EVTLMDTSKAQGELG EEEEEECCCCCCCCC | 23.02 | 16964243 | |
102 | Phosphorylation | VHVELQFTVRDCKSF EEEEEEEEEEECCCC | 11.15 | 27174698 | |
146 | Phosphorylation | RPLFQKVTTVAADQS CCHHHCCEEEECCCC | 23.69 | 29978859 | |
147 | Phosphorylation | PLFQKVTTVAADQSF CHHHCCEEEECCCCE | 15.90 | 29978859 | |
153 | Phosphorylation | TTVAADQSFTIRDLV EEEECCCCEEHHHHH | 25.55 | 29978859 | |
155 | Phosphorylation | VAADQSFTIRDLVSG EECCCCEEHHHHHCC | 21.98 | 29978859 | |
196 | Phosphorylation | GACVALVSVRVFYQR CCEEEEEEEEHHHHH | 12.69 | 24719451 | |
340 | Phosphorylation | PSAPRNLSFSASGTQ CCCCCCEEEEECCCE | 22.24 | 26074081 | |
342 | Phosphorylation | APRNLSFSASGTQLS CCCCEEEEECCCEEE | 20.39 | 26074081 | |
344 | Phosphorylation | RNLSFSASGTQLSLR CCEEEEECCCEEEEE | 40.97 | 26074081 | |
346 | Phosphorylation | LSFSASGTQLSLRWE EEEEECCCEEEEEEE | 24.68 | 26074081 | |
349 | Phosphorylation | SASGTQLSLRWEPPA EECCCEEEEEEECCC | 13.18 | 24719451 | |
358 | Phosphorylation | RWEPPADTGGRQDVR EEECCCCCCCCCEEE | 43.58 | 26074081 | |
414 | N-linked_Glycosylation | NGLEPYANYTFNVEA CCCCCCCCEEEEEEE | 30.45 | UniProtKB CARBOHYD | |
478 | Ubiquitination | RPRSPGANLTYELHV CCCCCCCCCEEEEEE | 38.54 | 22817900 | |
482 | Ubiquitination | PGANLTYELHVLNQD CCCCCEEEEEECCCC | 27.45 | 22817900 | |
493 | Phosphorylation | LNQDEERYQMVLEPR CCCCHHHHHHHCCCE | 12.30 | 23403867 | |
504 | Phosphorylation | LEPRVLLTELQPDTT CCCEEEEEECCCCCE | 30.41 | 26503514 | |
510 | Phosphorylation | LTELQPDTTYIVRVR EEECCCCCEEEEEEE | 28.34 | 26503514 | |
511 | Phosphorylation | TELQPDTTYIVRVRM EECCCCCEEEEEEEE | 20.73 | 26503514 | |
512 | Phosphorylation | ELQPDTTYIVRVRML ECCCCCEEEEEEEEE | 10.26 | 26503514 | |
593 | Ubiquitination | TDVDREDKLWLKPYV CCCCHHHHCCCCCCC | 36.49 | 21906983 | |
597 | Ubiquitination | REDKLWLKPYVDLQA HHHHCCCCCCCCCCC | 23.79 | 21906983 | |
599 | Phosphorylation | DKLWLKPYVDLQAYE HHCCCCCCCCCCCCC | 12.66 | 22322096 | |
605 | Phosphorylation | PYVDLQAYEDPAQGA CCCCCCCCCCCCCCC | 14.12 | 22322096 | |
672 | Ubiquitination | GQWWNFLREATIMGQ CHHHHHHHHEEECCC | 27.63 | 22817900 | |
780 | Phosphorylation | LLDDFDGTYETQGGK EECCCCCCEECCCCE | 21.74 | 21082442 | |
781 | Phosphorylation | LDDFDGTYETQGGKI ECCCCCCEECCCCEE | 23.62 | 27273156 | |
783 | Phosphorylation | DFDGTYETQGGKIPI CCCCCEECCCCEECE | 23.31 | 28152594 | |
787 | Ubiquitination | TYETQGGKIPIRWTA CEECCCCEECEEEEC | 52.73 | 22817900 | |
805 | Phosphorylation | IAHRIFTTASDVWSF HHHHHHCCHHHHHHH | 17.26 | - | |
811 | Phosphorylation | TTASDVWSFGIVMWE CCHHHHHHHHHHCEE | 17.28 | - | |
892 | Phosphorylation | ANPHSLRTIANFDPR HCCCHHHHHCCCCCC | 29.72 | - | |
906 | Phosphorylation | RMTLRLPSLSGSDGI CCEEECCCCCCCCCC | 39.50 | 19664994 | |
908 | Phosphorylation | TLRLPSLSGSDGIPY EEECCCCCCCCCCCH | 40.36 | 30278072 | |
910 | Phosphorylation | RLPSLSGSDGIPYRT ECCCCCCCCCCCHHC | 29.32 | 19664994 | |
915 | Phosphorylation | SGSDGIPYRTVSEWL CCCCCCCHHCHHHHH | 19.59 | 23927012 | |
917 | Phosphorylation | SDGIPYRTVSEWLES CCCCCHHCHHHHHHH | 23.65 | 22167270 | |
919 | Phosphorylation | GIPYRTVSEWLESIR CCCHHCHHHHHHHHH | 23.57 | 22167270 | |
924 | Phosphorylation | TVSEWLESIRMKRYI CHHHHHHHHHHHHHH | 17.21 | 22167270 | |
930 | Phosphorylation | ESIRMKRYILHFHSA HHHHHHHHHHHHHHC | 11.43 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EPHA1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EPHA1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-780; TYR-781; SER-906;SER-908; SER-910 AND SER-919, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33 AND SER-34, AND MASSSPECTROMETRY. |